Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 15/20 | 0.53 |
| ▸ | SRC | P12931 | 3/20 | 0.41 |
| ▸ | FYN | P06241 | 2/20 | 0.41 |
| ▸ | WEE2 | P0C1S8 | 2/20 | 0.40 |
| ▸ | WEE1 | P30291 | 2/20 | 0.40 |
| ▸ | PKMYT1 | Q99640 | 2/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.40 |
| ▸ | STK25 | O00506 | 1/20 | 0.40 |
| ▸ | CIT | O14578 | 1/20 | 0.40 |
| ▸ | RIOK3 | O14730 | 1/20 | 0.40 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | CASK | O14936 | 1/20 | 0.40 |
| ▸ | GAK | O14976 | 1/20 | 0.40 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.40 |
| ▸ | MAP3K13 | O43283 | 1/20 | 0.40 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.40 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.40 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL729216 | 1.00 | PDE4B (0.53) | PDE4BSRCFYNWEE2WEE1 | |
| SCHEMBL730531 | 1.00 | PDE4B (0.53) | PDE4BSRCFYNWEE2WEE1 | |
| SCHEMBL730860 | 1.00 | PDE4B (0.53) | PDE4BSRCFYNWEE2WEE1 | |
| SCHEMBL728879 | 0.99 | PDE4B (0.52) | PDE4BSRCFYNWEE2WEE1 | |
| SCHEMBL729406 | 0.98 | PDE4B (0.51) | PDE4BSRCFYNWEE2WEE1 | |
| SCHEMBL729258 | 0.97 | PDE4B (0.51) | PDE4BSRCFYNWEE2WEE1 | |
| SCHEMBL730443 | 0.94 | PDE4B (0.50) | PDE4BSRCADRA1A | |
| SCHEMBL728837 | 0.93 | PDE4B (0.50) | PDE4BSRCEGFR | |
| SCHEMBL730436 | 0.92 | PDE4B (0.51) | PDE4BSRCFYNABL1BCR | |
| SCHEMBL730970 | 0.92 | PDE4B (0.51) | PDE4BSRCFYNABL1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2482798-A1 | OLOPATADINE COMPOSITIONS AND USES THEREOF | Alcon Research, Ltd. (US) | 2012-08-08 | — | — | EP | claimed |
| EP-2467376-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | Kalypsys, Inc. (US) | 2012-06-27 | — | — | EP | claimed |
| US-8138205-B2 | Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 | KALYPSYS, INC. (US) | 2012-03-20 | — | — | US | claimed |
| WO-2011093924-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC (US) | 2011-08-04 | — | — | WO | claimed |
| WO-2011041640-A1 | OLOPATADINE COMPOSITIONS AND USES THEREOF | ALCON RESEARCH, LTD. (US) | 2011-04-07 | — | — | WO | claimed |
| US-20110082145-A1 | OLOPATADINE COMPOSITIONS AND USES THEREOF | ALCON RESEARCH, LTD. (US) | 2011-04-07 | — | — | US | claimed |
| US-20130045975-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC. (US) | 2013-02-21 | — | — | US | disclosed |
| US-20130045975-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC. (US) | 2013-02-21 | — | — | US | disclosed |
| US-20130045975-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC. (US) | 2013-02-21 | — | — | US | disclosed |
| EP-2482798-A1 | OLOPATADINE COMPOSITIONS AND USES THEREOF | Alcon Research, Ltd. (US) | 2012-08-08 | — | — | EP | disclosed |
| EP-2467376-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | Kalypsys, Inc. (US) | 2012-06-27 | — | — | EP | disclosed |
| US-8138205-B2 | Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 | KALYPSYS, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-8138205-B2 | Heteroarylalkoxy-substituted quinolone inhibitors of PDE4 | KALYPSYS, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| WO-2011093924-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011093924-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC (US) | 2011-08-04 | — | — | WO | disclosed |
| US-20110082145-A1 | OLOPATADINE COMPOSITIONS AND USES THEREOF | ALCON RESEARCH, LTD. (US) | 2011-04-07 | — | — | US | disclosed |
| WO-2011041640-A1 | OLOPATADINE COMPOSITIONS AND USES THEREOF | ALCON RESEARCH, LTD. (US) | 2011-04-07 | — | — | WO | disclosed |
| US-20100081646-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC. (US) | 2010-04-01 | — | — | US | disclosed |
| US-20100081646-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC. (US) | 2010-04-01 | — | — | US | disclosed |
| US-20100081646-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | KALYPSYS, INC. (US) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045975-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | PDE4B 2/4885SRC 3951/4885FYN 2070/4885 |
| US-20110082145-A1 | OLOPATADINE COMPOSITIONS AND USES THEREOF | PDE4B, PDE4A, PDE4C | PDE4B 1/4885SRC 4168/4885FYN 2092/4885 |
| US-20100081646-A1 | BICYCLIC HETEROARYL INHIBITORS OF PDE4 | PDE4A, PDE4B, PDE4C | PDE4B 2/4885SRC 3951/4885FYN 2070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.